Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Osteoarthritis Cartilage. 2021 Sep 16;30(9):1159–1173. doi: 10.1016/j.joca.2021.04.019

Table 2.

Routine interferents that can impact biomarker assays*.

Common endogenous interferents Interferent concentrations to test Examples of causes of high interferent concentrations Examples of assays impacted by interferent
Hemolysate (Hemoglobin) 0 - 500 mg/dL hemolysis Potassium, aspartate transaminase (AST), amylase, calcium, phosphorus, magnesium, total protein, and total and direct bilirubin
Triglycerides 0 - 1000 mg/dL (CLSI recommendation 3000 mg/dL) hyperlipemia phosphorus, creatinine, total protein, calcium, hemoglobin
Total Protein (from Albumin and gamma-globulins) 0 - 12 g/dL dehydration, multiple myeloma carbon dioxide, apolipoprotein AI, and apolipoprotein B
Bilirubin, conjugated 0 - 20 mg/dL hemolysis, gall bladder disease Creatinine, total protein and assays that use a peroxidase as the detection system
Bilirubin unconjugated 0 - 20 mg/dL liver disease assays that use a peroxidase as the detection system
*

modified from information available online from Sun Diagnostics (https://sundiagnostics.us/assurance/); CLSI, Clinical and Laboratory Standards Institute